#FusOnC2 and #PIDDN investigators are presenting posters at #Research4ChildhoodCancer .

🗣️ The #CancerMoonshot Scholars program seeks to diversify National Cancer Institute R01 portfolio and intends to support *45 new R01s* over the next three years.

Find out if this program can support + apply by November 8.

🔗 cancer.gov/moonshotschola…

OPA is a part of the Office of the Director, which has always been on the forefront of data analysis.

#TBT to when the Lawrence A. Tabak established a data processing facility with punch card equipment & biometric expertise in the 1960s!

📷 NIH History Office
📁 tinyurl.com/4zw7scej

In a study funded by National Cancer Institute, researchers Washington University in St. Louis developed a deep-scale #proteome and phosphoproteome database of #acutemyeloidleukemia that revealed post-transcriptionally regulated proteins associated with cancer-initiating events Blood Journal bit.ly/3yWMGDR.

In the last session of #2022FusOnC2 , moderated by James Amatruda Children's Hospital LA and Emily Theisen Nationwide Children's Hospital, investigators of #FusOnC2 are discussing opportunities and future directions for #ChildhoodCancer research. #Research4ChildhoodCancer

#PIDDN 2022 : Mackall Lab Stanford University is moderating a #PIDDN poster preview (a.k.a. lightning talk) session at #Research4ChildhoodCancer .